Go to the About Us section
Go to the Courses section
Go to the Research section
Go to the Specialist Services & Consultancy section
Go to the Outreach section
Go to the New Students section
New research by scientists at Oxford Brookes University has identified specific genes which could provide vital information about the biology of developmental coordination disorder (DCD), also known as dyspraxia.
Scientists at Oxford Brookes University have developed a new single-cell transcriptomic method which will aid multiple fields of biology, including the study of human health, disease and injury.
Medical research into eye genetics at Oxford Brookes University has received a funding pledge of £2 million from Baillie Gifford, an international investment business.
Scientists from three UK institutions including Oxford Brookes University have been awarded £2.3million to investigate how a parasite grows in humans.
Advances in DNA sequencing have uncovered a rare syndrome which is caused by variations in the gene SATB1. Discovery of this genetic syndrome is hoped to provide information to families and individuals affected by SATB1-syndrome
Scientific analysis of a protein enzyme found in COVID-19 could lead to the development of new drugs to treat the virus, research led by Oxford Brookes University scientists has found.
Oxford Brookes University is extending its international reach and impact with a new partnership in Sri Lanka, delivering degree programmes with the British College of Applied Studies (BCAS Campus).
Numerous animals may be vulnerable to SARS-CoV-2, the virus that causes Covid-19, according to a large study modelling how the virus might infect different animals’ cells, involving Oxford Brookes University academics.
Oxford Brookes spinout company Oxford Expression Technologies has been awarded a grant from Innovate UK to support a partnership with Vaxine Pty Ltd to develop a vaccine for COVID-19.